LA JOLLA IMMUNOLOGY CONFERENCE (EIN 843705461) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2019

Legal Domicile

Principal Officer

Hilde Cheroutre PhD

Phone

8587526819

Tax Period

2022-01-01 to 2022-12-31

LA JOLLA IMMUNOLOGY CONFERENCE, founded in 2019, is a small nonprofit in the Medical Research sector that reported $104K in total revenue in fiscal year 2022. Revenue surged 460% from the prior year, signaling strong growth momentum. The organization ran a surplus of $50K, a strong 48% operating margin.

Mission

The La Jolla Immunology Conference is an annual 3-day conference which brings together immunologists, primarily from Southern California to learn about and discuss the latest findings in immunology and fosters collaborations between immunologists working in academia and industry.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $103,990

Investment Income $40

Other Revenue $0

TOTAL REVENUE $104,030

Expense Breakdown

Grants Paid $0

Salaries & Benefits $19,636

Fundraising Expenses $0

Program Expenses $49,705

Other Expenses $34,047

TOTAL EXPENSES $53,683

Year-over-Year Comparison

	2022	2021	Change
Revenue	$104,030	$18,588	+4.6%
Expenses	$53,683	$26,449	+1.0%
Net Income	$50,347	$-7,861	-7.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Li-Fan Lu PhD	Pres & Co-Chair	1.00	Officer Director	$0	$0	$0
Hilde Cheroutre PhD	VP - Chair	1.00	Officer Director	$0	$0	$0
Manuela Raffatellu MD	Director	0.50	Director	$0	$0	$0
Stephan Hedrick PhD	Director	0.50	Director	$0	$0	$0
Linda Sherman PhD	Director	0.50	Director	$0	$0	$0
David R Webb PhD	Director	0.50	Director	$0	$0	$0
Susan Kaech PhD	Director	0.00	Director	$0	$0	$0
Karen Barnes	Sec/Treasurer	3.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	$104,030	$53,683	$243,138	$50,347
2021	$18,588	$26,449	$192,791	$-7,861
2020	$218,974	$24,257	$200,652	$194,717

LA JOLLA IMMUNOLOGY CONFERENCE